Advertisement
Advertisement

INDP

INDP logo

Indaptus Therapeutics Inc

1.01
USD
+0.01
+1.00%
Dec 16, 14:01 UTC -5
Closed
...

Indaptus Therapeutics Inc Profile

About

Indaptus Therapeutics approach is based on the hypothesis which efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals. Indaptus Therapeutics, formerly known as Intec Parent Inc., is based in NEW YORK.

Info & Links

CEO

Jeffrey A. Meckler

Headquarters

3 COLUMBUS CIRCLE, 15TH FLOOR
NEW YORK, NY 10019, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

https://indaptusrx.com

Auditor

Haskell & White LLP

Share holders

--

Employees

7

Indaptus Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

10.30M

Enterprise Value

2.92M

Enterprise Value/EBITDA(ttm)

-0.19

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.70

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-177.27%

Return on Invested Capital(ttm)

-190.05%

Return on Assets(ttm)

-141.06%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-15.37M

Net Income Available to Common(ttm)

-14.89M

Diluted EPS(ttm)

-1.71

Share Statistics

Beta (5Y Monthly)

1.46

52-Week Change

-52.58%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

10.20M

Dividend Yield

0.00%

Float4

7.19M

% Held by Insiders

29.50%

% Held by Institutions

7.06%

Balance Sheet

Total Cash(mrq)

7.38M

Total Cash Per Share(mrq)

0.72

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.42%

Quick Ratio(mrq)

3.42%

Book Value Per Share(mrq)

0.59

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.94

Free Cash Flow(ytd)

-8.93M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement